Lucid Diagnostics (LUCD) Return on Capital Employed (2021 - 2026)
Lucid Diagnostics posted quarterly Return on Capital Employed of 149.92% for Q1 2026, down 114178.0% year-on-year from N/an in Q1 2025, and down 124.45% on a QoQ basis from 66.79% in Q4 2025.
Lucid Diagnostics (LUCD) has 6 years of Return on Capital Employed data on file, last reported at 149.92% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 114178.0% year-over-year to 149.92%; the trailing twelve-month figure through Mar 2026 stood at 149.92% (down 114178.0% YoY), and the FY2025 full-year result was 174.08%, up 66805.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 149.92%, down from 66.79% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 991.86% in Q1 2025 and bottomed at 5540.8% in Q4 2023.
- The 5-year median for Return on Capital Employed is 260.61% (2024), against an average of 596.16%.
- The widest annual swing landed in 2023, when Return on Capital Employed tumbled 533260 bps; it then soared 407063 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 208.2% in 2022, then sank by 2561 bps to 5540.8% in 2023, then surged by 73 bps to 1470.17% in 2024, then jumped by 95 bps to 66.79% in 2025, then plunged by 124 bps to 149.92% in 2026.
- The last three Return on Capital Employed figures came in at 149.92% (Q1 2026), 66.79% (Q4 2025), and 243.33% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Lucid Diagnostics | 145.00 Mn | 117.12 Mn | -325,000.00 | -149.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -149.92% |
| Dec 31, 2025 | -66.79% |
| Sep 30, 2025 | -243.33% |
| Jun 30, 2025 | -760.17% |
| Mar 31, 2025 | 991.86% |
| Dec 31, 2024 | -1,470.17% |
| Sep 30, 2024 | -319.93% |
| Jun 30, 2024 | -260.61% |
| Mar 31, 2024 | -464.34% |
| Dec 31, 2023 | -5,540.80% |
| Sep 30, 2023 | -680.59% |
| Jun 30, 2023 | -288.94% |
| Mar 31, 2023 | -334.58% |
| Dec 31, 2022 | -208.20% |
| Sep 30, 2022 | -163.15% |
| Jun 30, 2022 | -97.38% |
| Mar 31, 2022 | -77.64% |
| Dec 31, 2021 | -101.98% |